SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-20-000026
Filing Date
2020-06-17
Accepted
2020-06-17 16:38:53
Documents
4
Effectiveness Date
2020-06-17

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_2018planamendment.htm S-8 138732
2 EXHIBIT 5.1 alpn-ex51_20200617.htm EX-5.1 9097
3 EXHIBIT 23.1 alpn-ex231x20200617.htm EX-23.1 2477
4 alpnex5120200616image1a01.gif GRAPHIC 3351
  Complete submission text file 0001626199-20-000026.txt   156254
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239233 | Film No.: 20970207
SIC: 2834 Pharmaceutical Preparations